This investment follows a multi-facility modernization pattern the company has executed across Alabama, Wisconsin, Louisiana, and Oregon in recent years
Decision Focus
Georgia-Pacific announced on October 28, 2026 that it will spend approximately $150 million to rebuild the Number Four paper machine at its Palatka, Florida mill—a machine that has run since 1980. Work has already started, with completion targeted for the second quarter of 2028. The machine produces paper for Angel Soft bath tissue, one of several consumer brands that collectively reach nearly 60 million U.S. households. For South Florida business owners who purchase these product categories at any scale—hospitality, healthcare, food service, retail, office management—the operational signal is supply reliability, not disruption.
90-Second Brief
This week, georgia-Pacific is replacing aging manufacturing infrastructure at a Florida facility that supplies some of the country’s most widely distributed consumer tissue brands. The rebuilt machine is expected to improve safety, output reliability, and product quality when it comes online in mid-2028. This investment follows a multi-facility modernization pattern the company has executed across Alabama, Wisconsin, Louisiana, and Oregon in recent years. South Florida buyers, the near-term implication is continuity; the medium-term implication is a supply base running on updated equipment rather than infrastructure from the Carter administration.
What Is Really Happening?
Georgia-Pacific is not adding a new machine—it is replacing one that has operated for roughly 46 years. That distinction matters. Aging paper machine infrastructure carries increasing maintenance costs, unplanned downtime risk, and quality variance. A rebuild at this scale signals that the company views Florida-based tissue production as a long-term competitive asset worth protecting rather than consolidating away.
The Palatka mill holds a strategic position in Georgia-Pacific’s network: it controls its own pulp supply, has existing converting infrastructure, and sits in a geographic position that serves southeastern and Gulf Coast distribution efficiently. Replacing the Number Four machine—rather than shutting it down or relocating production—reinforces that the mill is being strengthened, not wound down. That pattern has repeated at Georgia-Pacific’s Wauna, Oregon mill, where a comparable rebuild exceeded $150 million and has already been completed.
Why It Matters for South Florida Business Owners
The businesses most directly affected operate in categories where tissue and paper products are a recurring line item: hotels, restaurants, assisted living and medical offices, gyms, salons, retail stores, and professional service offices with high foot traffic. Angel Soft, Brawny, Quilted Northern, and Sparkle are among the highest-volume brands in commercial purchasing.
When a major manufacturer invests this heavily in modernizing a production asset, the downstream effect is typically better supply consistency and more competitive pricing stability on high-volume SKUs. The transition period is also worth tracking: construction is underway now through Q2 2028, and large paper machine rebuilds can involve temporary production adjustments at the affected facility. Any South Florida buyer operating on lean inventory practices—particularly in hospitality or healthcare where tissue restocking is time-sensitive—should be aware that one production line in Palatka will be in active rebuild mode for the next 18 months.
This is not cause for supply disruption alarm. Georgia-Pacific’s announcement explicitly states the project is designed to preserve existing production while increasing capabilities, meaning the intent is continuity, not a gap. That said, operators who rely on specific SKU availability from a single distributor should verify their supply chain’s exposure to single-facility sourcing on these categories.
Forward View
Three fronts are worth tracking as this project moves toward its 2028 completion date.
First, pricing on commercial tissue and paper products. Modernized machinery typically reduces per-unit production cost over time. Whether those efficiencies flow to commercial buyers will depend on competitive dynamics in the distributor tier, but South Florida hospitality and healthcare operators negotiating annual supply contracts in 2027 or early 2028 should factor in the industry’s capacity investment cycle.
Second, Florida’s manufacturing footprint more broadly. Georgia-Pacific employs approximately 30,000 people directly across more than 150 facilities nationwide. Investments of this size in Florida suggest that large industrial operators still view the state as a viable long-term manufacturing location. For South Florida business owners who track regional economic signals, a $150 million commitment to north-central Florida is a meaningful data point.
Third, private-label positioning. The most recently completed rebuild at Georgia-Pacific’s Wauna mill produces both Angel Soft and strategic private-label bath tissue. If the rebuilt Palatka machine follows a similar product mix, it could affect availability and pricing on private-label tissue products that compete directly with branded SKUs in commercial distribution—a detail relevant to any buyer optimizing cost-per-unit across product tiers.
What Is Still Uncertain
The source announcement does not specify whether the Palatka rebuild will involve any scheduled production curtailment, or whether parallel machine capacity will fully offset output during the transition. The project’s impact on specific SKU availability between now and Q2 2028 is not confirmed. It is also not confirmed whether this rebuild will alter Georgia-Pacific’s distribution priorities across Florida’s regional markets, including the Miami-Dade, Broward, and Palm Beach corridor.
Georgia-Pacific has not announced site selections for additional paper machine investments it described in May 2026 for central and western U.S. facilities. How those projects interact with Palatka’s capacity going forward remains an open question.
One Question for Your Team
Does your current purchasing agreement for tissue and paper products specify the distribution source or mill origin for the SKUs you buy at volume—and if a single Florida facility goes through an 18-month equipment transition, do you have a secondary supplier or distributor relationship ready to activate?
Sources
- Prnewswire — Georgia-Pacific Investing Approximately $150 Million in Palatka, Florida, to Modernize Angel Soft® Bath (Link)